NASDAQ · Biotechnology

Ocugen Inc (OCGN)

$0.77 +4.79%
39 In band Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$1.40-45.15%

Company profile

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania.

SectorHealthcare
IndustryBiotechnology
Market cap$296.42M
P/E ratioNone
EPS$-0.20
Beta1.982
Dividend yield0.00%
52-week high$2.73
52-week low$0.69

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for OCGN

An email when OCGN closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 6:58 AM EST